Afficher la notice abrégée

dc.rights.licenseopenen_US
dc.contributor.authorHOUGHTALING, L.
dc.contributor.authorMOH, Desmorys Raoul
dc.contributor.authorABDOU CHEKARAOU, M.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorGABILLARD, Delphine
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorANGLARET, Xavier
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorEHOLIE, Serge Paul
dc.contributor.authorZOULIM, F.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorDANEL, Christine
dc.contributor.authorLACOMBE, K.
dc.contributor.authorBOYD, A.
dc.date.accessioned2020-11-17T08:23:49Z
dc.date.available2020-11-17T08:23:49Z
dc.date.issued2018-05
dc.identifier.issn1931-8405 (Electronic) 0889-2229 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/14045
dc.description.abstractEnImmunorecovery could be attenuated in HIV-hepatitis B virus (HBV) co-infection versus HIV mono-infection during antiretroviral therapy (ART), yet whether it also occurs in individuals from Sub-Saharan Africa without severe co-morbidities is unknown. In this study, 808 HIV-infected patients in Cote d'Ivoire initiating continuous ART were included. Six-month CD4+ count trajectories and the proportion reaching CD4+ T-cell counts >350/mm3, HIV-RNA <300 copies/mL, still alive and not lost to follow-up within 18 months ("optimal immunorecovery") were compared between co-infected groups. At inclusion, 80 (9.9%) patients were HIV-HBV co-infected, 40 (50.0%) of whom had high HBV-DNA viral load (>104 copies/mL). Co-infected patients with high HBV-DNA replication initiated ART with significantly lower median CD4+ T-cell counts (216/mm3, IQR=150-286) compared to co-infection with low HBV-DNA replication (268/mm3, IQR=178-375) or HIV mono-infection (257/mm3, IQR=194-329) (p=0.003). These patients had significantly faster rates of CD4+ cell count increase from baseline after adjusting for baseline age, WHO stage III/IV and CD4+ cell counts (p=0.04), yet were not more likely to exhibit optimal immunorecovery (82.5% versus 80.0% and 77.9%, respectively) (p=0.8). In conclusion, change in CD4+ cell counts after ART-initiation was accelerated in co-infected patients with high HBV DNA viral loads, but this did not lead to increased rates of optimal immunorecovery.
dc.language.isoENen_US
dc.subject.enIDLIC
dc.subject.enPACCI
dc.title.enCD4+ T Cell Recovery and Hepatitis B Virus Coinfection in HIV-Infected Patients from Cote d'Ivoire Initiating Antiretroviral Therapy
dc.title.alternativeAIDS Res Hum Retrovirusesen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1089/aid.2017.0272en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed29466862en_US
bordeaux.journalAIDS Research and Human Retrovirusesen_US
bordeaux.page439-445en_US
bordeaux.volume34en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue5en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamIDLICen_US
bordeaux.teamPACCIen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03194156
hal.version1
hal.date.transferred2021-04-09T11:16:43Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft.jtitle=AIDS%20Research%20and%20Human%20Retroviruses&amp;rft.date=2018-05&amp;rft.volume=34&amp;rft.issue=5&amp;rft.spage=439-445&amp;rft.epage=439-445&amp;rft.eissn=1931-8405%20(Electronic)%200889-2229%20(Linking)&amp;rft.issn=1931-8405%20(Electronic)%200889-2229%20(Linking)&amp;rft.au=HOUGHTALING,%20L.&amp;MOH,%20Desmorys%20Raoul&amp;ABDOU%20CHEKARAOU,%20M.&amp;GABILLARD,%20Delphine&amp;ANGLARET,%20Xavier&amp;rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée